CTC Clinical Trial Consultants AB — Clinical Trial Site

67 Registered trials

11 Currently recruiting

Organisation

CTC Clinical Trial Consultants AB

Location

Uppsala, Sweden

Identifier

ORG-100028585

Address

Vetenskapens Graend 11, 431 53, Sweden

Departments

#7510
#7511
#7512
Akademiska sjukhuset
Clinical Trial Consultants AB
Clinical Trial Consultants AB, Dag Hammarskjöldsväg 14, 752 37 Uppsala
Clinical trials
CTC
CTC AB
CTC Akademiska
CTC Clinical Trial Consultants
CTC Clinical Trial Consultants AB
CTC Clinical Trial Consultants AB, CTC Karolinska
CTC Ebbe Park
CTC EbbePark Linköping
CTC Ebbepark, Linköping
CTC GoC Gothenburg
CTC GoCo
CTC GoCO Molndal
CTC GoCo Möndal
CTC Karolinska
CTC Karolinska Stockholm
CTC MTC
CTC MTC, Uppsala
CTC Oscar
CTC Uppsala
Department Lung- och allergy diseases
Dermatology Department
Kardiologi
Lung- och allergimottagningen
Lungkliniken
MTC
N/A
NA
Uppsala University Hospital

Clinical trials at this site (67)

Search interface

An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo… Not authorised

2024-514496-18-00 Hepatocellular carcinoma, renal cell carcinoma and diff 3
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and imm… Pending

2024-515627-10-00 generalised myasthenia gravis 7
A Phase I trial to investigate the pharmacokinetics and ECG effects of single doses of linaprazan glurate administered as oral tablets to he… Pending

2024-516261-36-00 Erosive Gastroesophageal Reflux Disease (eGERD) 3
An adaptive, randomized, double-blind, single-center, placebo-controlled first-in-human study evaluating safety, tolerability and exposure o… Pending

2024-518698-32-00 Wound healing 1
A Phase 1, open label, randomised, 2-period, 2 sequence, 7-days repeat-dosing, crossover oral pharmacokinetic trial comparing multiple dosin… Pending

2025-524883-39-00 Cardiopulmonary diseases with contributions of thrombos 3
Exploratory, non-randomized, 3-group, microdosing clinical trial to investigate Gallium-68 (68Ga) labeled Platelet-Derived Growth Factor Be… Pending

2026-525309-11-00 Systemic Sclerosis-associated Interstitial Lung Disease 3
A positron emission tomography study of synaptic nerve cells proteins alpha-7 nicotinic acetylcholine receptors in brain of healthy voluntee… Recruiting

2024-515935-31-04 Alzheimer´s disease 1 2026-02-16
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Bronchiectasis 5 2025-08-21
A randomised, open-label, single-centre, drug-drug-interaction trial to evaluate the impact of carboxylesterase 2 (CES2)- and CYP3A4-inhibit… Recruiting

2026-526135-18-00 Idiopathic pulmonary fibrosis 3 2026-05-12
A study to measure how well seltorexant works in adult depressed patients and how safe it is both for short- and long-term use when taken wi… Recruiting

2023-509070-36-00 Major Depressive Disorder with Insomnia Symptoms 5 2025-03-18
A PHASE 2A, EXPLORATORY, TWO-PART, OPEN-LABLE TRIAL TO EVALUATE DOSE AND SAFETY OF NANOECHO PARTICLE-1 (FERUMOXTRAN) USING NANOECHO IMAGIN… Recruiting

2024-515335-29-00 Rectal cancer 4 2024-10-16
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
First-in-human (FIH), microdosing, non-randomized, clinical trial to investigate binding of positron emission tomography tracer [68Ga]Ga-DOT… Recruiting

2023-506555-15-00 Metabolic dysfunction-associated steatotic liver diseas 1 2024-08-19
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet Recruiting

2023-506150-21-00 Celiac Disease 4 2024-05-29
An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared … Ended

2025-523879-34-00 Nicotine use 2 2025-11-17
A Phase 1 open-label positron emission tomography TRIAL to assess changes in liver uptake of [68Ga]Ga-FAPI-46 following oral administration … Ended

2024-517605-91-00 advanced liver fibrosis 3 2025-05-26
A study to evaluate the treatment response and safety of two dose regimens of subcutaneous amlitelimab compared with treatment withdrawal in… Ended

2023-508096-36-00 atopic dermatitis 5 2024-10-30
A Phase 2a/b study of the efficacy and safety of subcutaneous amlitelimab in adults with non-responsive celiac disease Ended

2024-511213-38-00 Coeliac disease 4 2024-10-15
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants with Severe Alopecia Areata Ended

2023-505061-82-01 Alopecia Areata 5 2024-06-17
Randomized, Double-Blind, Placebo-Controlled, Multiple-Attack Study with an Open-Label Extension to Evaluate the Efficacy, Safety, Tolerabil… Ended

2023-506029-12-00 Migraine 5 2024-04-03
A Phase III study to investigate two initial administrations of COMP360 in treatment-resistant depression Ended

2023-505268-12-00 Treatment-resistant depression 5 2024-02-09
A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokine… Ended

2023-504215-32-00 Overweight and obesity 9 2023-09-28
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04